Abrahams Brett

Abrahams Brett

Founder at Heppinn Biosciences

Health Technology
Consumer Services
Finance

Profile

Abrahams Brett is the founder of Heppinn Biosciences, which was founded in 2020.
Currently, Dr. Brett serves as an advisory board member for Accelerator Services Corp, Foundation for Angelman Syndrome Therapeutics, and Cureshank.
Dr. Brett previously held positions as Senior Director at Ovid Therapeutics, Inc. in 2018 and as Executive Vice-President at Magnolia Neurosciences Corp.
from 2018 to 2022.
Dr. Brett received an undergraduate degree from Queen's University in 1997 and a doctorate degree from the University of British Columbia in 2004.

Abrahams Brett active positions

CompaniesPositionStart
Consultant / Advisor 2022-01-31
Heppinn Biosciences Founder 2020-10-31
Consultant / Advisor 2022-08-31
Cureshank Consultant / Advisor 2019-08-31
All active positions of Abrahams Brett

Former positions of Abrahams Brett

CompaniesPositionEnd
Private Equity Investor 2022-02-27
OVID THERAPEUTICS INC. Director/Board Member 2018-08-29
See the detail of Abrahams Brett's experience

Training of Abrahams Brett

Queen's University Undergraduate Degree
University of British Columbia Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Abrahams Brett's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
OVID THERAPEUTICS INC.

Health Technology

Private companies5

Finance

Commercial Services

Health Technology

Heppinn Biosciences

Cureshank

See company connections
  1. Stock Market
  2. Insiders
  3. Abrahams Brett